🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Gabapentin - Medicines in Ireland

24 authorised products containing Gabapentin, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 24 authorised medicines
MedicineActive substanceLicence holderStatus
Gabapentin 100 mg hard capsules
PA2315/164/003
 Gabapentin Accord Healthcare Ireland Ltd. Not marketed
Gabapentin 300 mg hard capsules
PA2315/164/004
 Gabapentin Accord Healthcare Ireland Ltd. Not marketed
Gabapentin 400 mg hard capsules
PA2315/164/005
 Gabapentin Accord Healthcare Ireland Ltd. Not marketed
Gabapentin 600 mg film-coated tablets
PA2315/164/001
 Gabapentin Accord Healthcare Ireland Ltd. Not marketed
Gabapentin 800 mg film-coated tablets
PA2315/164/002
 Gabapentin Accord Healthcare Ireland Ltd. Not marketed
Gabapentin Auro 100 mg hard capsules
PA1445/026/001
 Gabapentin Aurobindo Pharma (Malta) Limited —
Gabapentin Auro 300 mg hard capsules
PA1445/026/002
 Gabapentin Aurobindo Pharma (Malta) Limited —
Gabapentin Auro 400 mg hard capsules
PA1445/026/003
 Gabapentin Aurobindo Pharma (Malta) Limited —
Gabapentin Rosemont 50 mg/ml Oral Solution
PA23081/010/001
 Gabapentin Taw Pharma (Ireland) Limited Marketed
Gabapentin Thame 50 mg/ml oral solution
PA22697/025/001
 Gabapentin Syri Pharma Limited t/a Thame Laboratories Marketed
Gabin 100 mg capsules, hard
PA1445/020/001
 Gabapentin Aurobindo Pharma (Malta) Limited Marketed
Gabin 300 mg capsules, hard
PA1445/020/002
 Gabapentin Aurobindo Pharma (Malta) Limited Marketed
Gabin 400 mg capsules, hard
PA1445/020/003
 Gabapentin Aurobindo Pharma (Malta) Limited Marketed
Neurontin 100 mg hard capsules
PA23355/051/001
 Gabapentin Viatris Healthcare Limited Marketed
Neurontin 300 mg hard capsules
PA23355/051/002
 Gabapentin Viatris Healthcare Limited Marketed
Neurontin 400 mg hard capsules
PA23355/051/003
 Gabapentin Viatris Healthcare Limited Marketed
Neurontin 600 mg film-coated tablets
PA23355/051/004
 Gabapentin Viatris Healthcare Limited Marketed
Neurontin 800 mg film-coated tablets
PA23355/051/005
 Gabapentin Viatris Healthcare Limited Marketed
Neurostil 100 mg capsules, hard
PA0749/164/001
 Gabapentin Teva Pharma B.V. Not marketed
Neurostil 100 mg hard capsules
PA1986/128/001
 Gabapentin Teva B.V. Not marketed
Neurostil 300 mg capsules, hard
PA0749/164/002
 Gabapentin Teva Pharma B.V. Not marketed
Neurostil 300 mg hard capsules
PA1986/128/002
 Gabapentin Teva B.V. Not marketed
Neurostil 400 mg capsules, hard
PA0749/164/003
 Gabapentin Teva Pharma B.V. Not marketed
Neurostil 400 mg hard capsules
PA1986/128/003
 Gabapentin Teva B.V. Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.